MentionFox
Home › Executive changes › Myriad Genetics Inc
Leadership changes · SEC Form 8-K, Item 5.02

Myriad Genetics Inc executive changes

Every leadership change Myriad Genetics Inc reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Appointments named1
Latest filing2026-09-16

Myriad Genetics Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-16. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-09-16 · 8-K

Appointed: Vishal Sikri, Senior Vice President, Product, effective 2026-09-16

On September 15, 2026, the Company's Board of Directors (the "Board") appointed Vishal Sikri, currently serving as the Company's Senior Vice President, Product, as the Company's Executive Vice President, Commercial, effective September 16, 2026.
Filed 2026-06-23 · 8-K

Reported

On June 17, 2026, Daniel M. Skovronsky M.D., Ph.D., a member of the Board of Directors of Myriad Genetics, Inc. (the "Company") notified the Company that he is resigning as a director, effective immediately.
Hiring for a seat like this?

Find people with the same kind of experience as the Senior Vice President, Product at Myriad Genetics Inc, with the record behind each one.

Find candidates like Product at Myriad Genetics Inc
Selling to Myriad Genetics Inc?

New leaders review vendors and budgets in their first months. Get an alert the next time Myriad Genetics Inc is in the news or changes leadership.

Get an alert when Myriad Genetics Inc changes leadership

Tools for this story

Each opens in a new tab, filled in for Myriad Genetics Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/myriad-genetics
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Myriad Genetics Inc (MYGN) executive changes: Vishal Sikri appointed, Product. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/myriad-genetics